• 21302 Citations
  • 55 h-Index
1982 …2019
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Vanna Chiarion Sileni is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 5 Similar Profiles
Melanoma Medicine & Life Sciences
Survival Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Esophageal Neoplasms Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
Safety Medicine & Life Sciences
Neoplasm Metastasis Medicine & Life Sciences
Neoplasms Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1982 2019

  • 21302 Citations
  • 55 h-Index
  • 207 Article
  • 3 Review article
  • 1 Chapter
2 Citations (Scopus)

An open-label, multicentre safety study of vemurafenib in patients with BRAFV600-mutant metastatic melanoma: final analysis and a validated prognostic scoring system

Larkin, J., Brown, M. P., Arance, A. M., Hauschild, A., Queirolo, P., Vecchio, M. D., Ascierto, P. A., Krajsová, I., Schachter, J., Neyns, B., Garbe, C., Sileni, V. C., Mandalà, M., Gogas, H., Espinosa, E., Hospers, G., Lorigan, P., Nyakas, M., Guminski, A., Liszkay, G. & 5 others, Rutkowski, P., Miller, W., Donica, M., Makrutzki, M. & Blank, C., Jan 1 2019, In : European Journal of Cancer. 107, p. 175-185 11 p.

Research output: Contribution to journalArticle

Multicenter Studies
Melanoma
Safety
Mutation
PLX4032

An open-label, multicentre safety study of vemurafenib in patients with BRAFV600-mutant metastatic melanoma: final analysis and a validated prognostic scoring system

Larkin, J., Brown, M. P., Arance, A. M., Hauschild, A., Queirolo, P., Vecchio, M. D., Ascierto, P. A., Krajsová, I., Schachter, J., Neyns, B., Garbe, C., Sileni, V. C., Mandalà, M., Gogas, H., Espinosa, E., Hospers, G., Lorigan, P., Nyakas, M., Guminski, A., Liszkay, G. & 5 others, Rutkowski, P., Miller, W., Donica, M., Makrutzki, M. & Blank, C., Jan 2019, In : European Journal of Cancer. 107, p. 175-185 11 p.

Research output: Contribution to journalArticle

Multicenter Studies
Melanoma
Safety
Mutation
PLX4032
3 Citations (Scopus)

Clonal heterogeneity of melanoma in a paradigmatic case study: Future prospects for circulating melanoma cells

Scaini, M. C., Pigozzo, J., Pizzi, M., Manicone, M., Chiarion-Sileni, V., Zambenedetti, P., Rugge, M., Zanovello, P., Rossi, E., Zamarchi, R. & Facchinetti, A., Feb 1 2019, In : Melanoma Research. 29, 1, p. 89-94 6 p.

Research output: Contribution to journalArticle

Melanoma
Clone Cells
Neoplasm Metastasis
Mutation
Neoplasms

Effectiveness of dabrafenib in the treatment of patients with BRAF V600-mutated metastatic melanoma in a Named Patient Program

Martin-Algarra, S., Hinshelwood, R., Mesnage, S., Cebon, J., Ferrucci, P. F., Aglietta, M., Neyns, B., Chiarion-Sileni, V., Lindsay, C. R., Del Vecchio, M., Linardou, H., Merelli, B., Tonini, G., Atkinson, V., Freivogel, K., Stein, D., Dalland, L., Lau, M., Legenne, P., Queirolo, P. & 1 others, Millward, M., 2019, In : Melanoma Research. 29, 5, p. 527-532 6 p.

Research output: Contribution to journalArticle

Melanoma
Confidence Intervals
Therapeutics
Disease-Free Survival
Fever
2 Citations (Scopus)

Germline and somatic mutations in patients with multiple primary melanomas: A next generation sequencing study

Casula, M., Paliogiannis, P., Ayala, F., De Giorgi, V., Stanganelli, I., Mandalà, M., Colombino, M., Manca, A., Sini, M. C., Caracò, C., Ascierto, P. A., Satta, R. R., Dedola, M. F., Denti, S., Fedeli, M. A., Montesu, M. A., Profili, S., Scotto, T., Sini, G., Tanda, F. & 9 others, Lissia, A., Cossu, A., Palmieri, G., Ghiorzo, P., Queirolo, P., Quaglino, P., Botti, G., Sileni, V. C. & Di Giacomo, A. M., Aug 5 2019, In : BMC Cancer. 19, 1, 772.

Research output: Contribution to journalArticle

Open Access
Germ-Line Mutation
Melanoma
Mutation
Italy
Population